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Abstract
After 12, 18, and 24 h of oral administration of carbon tetrachloride (as a 1:1 mixture with mineral oil : 4 ml/kg body
weight) to rats, the activity of caspase-3-like protease in the liver increased significantly compared to that in the control group
that was given mineral oil (4 ml/kg). In plasma, the activity of caspase-3 was barely detectable in the control rat, but increased
significantly 24 h after drug administration along with a dramatic increase in glutamate oxaloacetate transaminase. These
results indicate that carbon tetrachloride causes apoptosis in the liver by activating caspase-3, which is released to plasma by
secondary necrosis. After 18 and 24 h of carbon tetrachloride administration, the liver concentration of hydrophilic vitamin
C was decreased significantly, while that of hydrophobic vitamin E was not affected. The plasma concentration of vitamins C
and E was not influenced significantly. These results suggest that carbon tetrachloride induces oxidative stress mainly in the
aqueous phase of the liver cell. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
It is well established that carbon tetrachloride
(CCl4) is a typical hepatotoxin causing centrizonal
necrosis [1]. As a result of extensive studies, the ini-
tial event in the rat given CCl4 has been believed to
be lipid peroxidation of the endoplasmic reticulum of
the liver cell initiated by trichloromethyl radical gen-
erated by the reaction between CCl4 and cytochrome
P450 [1,2]. Based on these results, CCl4 has been
assumed to be a typical poison causing severe oxida-
tive stress. However, we reported [3] that the level of
speci¢cally determined lipid hydroperoxides [4],
which was shown to be a good indicator of oxidative
stress in typical pathologic conditions such as vita-
min E de¢ciency [5], iron overload [6], diabetes [7],
and thioacetamide intoxication [8], was increased by
CCl4 only in mitochondria. It has long been known
[3,9,10] that thiobarbituric acid-reactive substances
(TBARS), which were widely used index of lipid per-
oxidation, does not increase signi¢cantly in the liver
of rats treated with CCl4. These observations suggest
that CCl4 does not cause extensive lipid peroxidation
as widely accepted. To evaluate the oxidative stress
caused by CCl4, changes in the concentration of anti-
oxidative vitamins C and E in the liver and plasma
were measured in this study.
In the previous study [3], we also demonstrated
that CCl4 inactivated cytochrome oxidase in mito-
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chondria. Recent studies show the key role of mito-
chondria in apoptosis [11]. Histological study [12]
suggests that apoptosis is induced by CCl4 in the
liver. To elucidate the mechanism of apoptosis
caused by CCl4, caspase-3 activity was measured.
As a result, we have found that the apoptosis caused
by CCl4 involves the activation of caspase-3 as in the
case of thioacetamide [8], a well-known hepatotoxin
causing hepatocellular necrosis as does CCl4 [1,13].
2. Materials and methods
2.1. Animals
Guidelines from the Prime Minister’s O⁄ce of Ja-
pan (No. 6 of 27 March, 1980) for the care and use
of laboratory animals were followed. Male rats
(SLC: Wistar strain) were obtained from Japan
SLC Co. (Hamamatsu, Shizuoka, Japan). The ani-
mals were housed in a room at 24 þ 2‡C, and a
12:12-h light/dark cycle. Animals were fed commer-
cial laboratory chow (MF, Oriental Yeast Co., Osa-
ka, Japan) and water ad libitum. Six-week-old rats
were administered a mixture of CCl4 and mineral oil
(1:1, 4 ml/kg body weight) through an intragastric
tube. The control rats received mineral oil alone (4
ml/kg body weight).
2.2. Analytical methods
Rats were anesthetized with diethyl ether and
killed by collecting the blood from the inferior
vena cava using a syringe containing sodium heparin
as an anticoagulant. After perfusion of ice-cooled
saline through the portal vein, organs were removed.
The excised tissue was homogenized in 5 volumes of
phosphate-bu¡ered saline (10 mM, pH 7.4) under ice
cooling. All determinations were made in duplicate
experiments with 4^6 animals in each group. The
determination of vitamin C was made according to
a speci¢c and sensitive method [14,15] involving
chemical derivatization and HPLC. The concentra-
tion of K-tocopherol was determined by HPLC
[16]. The conditions of HPLC and £uorescence de-
tection (Shimadzu RF-535, Kyoto, Japan) were re-
ported previously [17]. Blood was centrifuged at
13 000Ug for 5 min at 4‡C to separate plasma. The
activity of plasma glutamate oxaloacetate transami-
nase (GOT: EC 2.6.1.1) was determined using the
diagnostic kits (GOT-UV Test Wako, Wako Pure
Chemicals Co., Osaka, Japan) and expressed as Kar-
men units. Caspase-3 activity was determined as de-
scribed previously [8,18].
Protein concentrations were determined according
to the method of Lowry et al. [19] using bovine se-
rum albumin as the standard.
Data were expressed as mean þ S.D. and analyzed
by analysis of variance using StatView software
(Abacus Concepts, Berkeley, CA). Di¡erences be-
tween the group means were considered signi¢cant
at P6 0.05 using the Bonferroni/Dunn Procedure
generated by this program.
3. Results and discussion
3.1. Liver necrosis and apoptosis caused by CCl4
A necrogenic dose [3,20] of CCl4 as a 1:1 mixture
with mineral oil (4 ml/kg) was orally administered to
rats. After 12 and 18 h, the activity of plasma GOT
was signi¢cantly higher than that of the control
group which was administered mineral oil alone (4
ml/kg) (Table 1). After 24 h, the plasma GOT activ-
ity increased drastically compared to that of the con-
trol group. These results showed that the necrotic
process had initiated at 12 h and proceeded there-
after, in agreement with the literature [3].
Shi et al. [12] reported that apoptosis in the rat
liver was observed histochemically after CCl4 admin-
istration. To elucidate the mechanism of apoptosis,
the activity of caspase-3-like protease, a cysteine pro-
tease speci¢cally involved in apoptosis [21], was de-
termined. Caspase-3-like protease activity in the liver
increased signi¢cantly compared to that in the con-
trol group 12, 18, and 24 h after CCl4 administration
(Table 1).
In plasma, the activity of caspase-3 was barely
detectable in the control rats and was increased sig-
ni¢cantly 24 h after drug administration along with a
dramatic increase in GOT (Table 1). It is surprising
that caspase-3, a protease showed activity in plasma,
which has a strong anti-protease activity. These re-
sults indicate that the activity of caspase-3 in the
liver and plasma is a reliable biochemical indicator
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of apoptosis under pathological conditions. Because
apoptosis in animal tissue has been characterized by
morphological observations [12,22^24], it is generally
assumed that apoptotic cells in animal tissues are
phagocytosed rapidly by neighboring cells to prevent
in£ammation. It is conceivable that the clearing
mechanism hampered the histological detection of
apoptotic cells induced in the liver by CCl4 [24].
The increase of caspase-3 activity in the liver and
plasma was also reported [8,18], when thioacetamide
(500 mg/kg), a typical necrogenic toxin, was applied
to rats.
These results indicate that CCl4 causes apoptosis
in the liver by activating caspase-3 and that the ap-
optosis and necrosis proceed simultaneously in the
liver, from which caspase-3 is released by secondary
necrosis taking place around 24 h as shown by the
high plasma caspase-3 and GOT activities. It is well
documented [25] that procaspase-3 (CPP32) is acti-
vated by cytochrome c released from mitochondria.
We reported [3] that CCl4 damaged liver mitochon-
dria by inhibition of cytochrome oxidase as well as
by enhanced oxidative stress as evidenced by the in-
crease of lipid hydroperoxides. Therefore, it is sug-
gested that mitochondrial damage caused by CCl4 is
involved in the apoptotic process.
Jaeschke et al. [26] reported that endotoxin, a hep-
atotoxin leading to necrosis, causes 17-fold activa-
tion of caspase-3-like protease in mouse liver after
7 h of administration. The activation caused by en-
dotoxin is much higher than that observed in the
present study, although the animal species were dif-
ferent. The extent of apoptosis by CCl4 seems to be
much less than that by endotoxin. Therefore, it is
suggested that CCl4 mainly causes necrosis and par-
tial apoptosis leading to secondary necrosis, rather
than apoptosis and necrosis in a sequential fashion.
Since measurable caspase-3 activity is detected in
the control rat liver, it may be argued that the in-
crease in plasma caspase-3 activity is not caused by
apoptosis but is the result of leakage of basal levels
of caspase-3 from damaged hepatocytes into the
plasma in the same way as GOT is increased. To
evaluate the relative contribution of apoptosis to
plasma caspase-3 activity, we calculated the activity
ratio of plasma caspase-3 and GOT based on the
data of Table 1. If plasma caspase-3 activity origi-
nates solely from necrotic cells and not from apopto-
tic cells, this ratio is assumed to be constant. The
ratiosU104 were calculated to be 6.6, 4.1, 4.8, and
3.4, for 12, 18, and 24 h of CCl4-treated rats and the
control rat, respectively. As this ratio for CCl4-in-
toxicated rats were all higher than that of the control
group, it is supported that plasma caspase-3 activity
is also derived from apoptotic cells in rats that were
given CCl4.
It is well known that CCl4 induces a zonal necrosis
[1]. Therefore, in zones of the liver where toxicity of
CCl4 is less severe, apoptosis may be induced instead
of necrosis and the increase in hepatic and plasma
levels of caspase-3 may originate from these cells.
3.2. Changes in the levels of vitamins C and E in rats
treated with CCl4
After 12 h of CCl4 administration, the hepatic lev-
el of hydrophilic vitamin C did not di¡er from that
in the control group (Table 2) and it decreased dras-
Table 1
Activities of caspase-3-like protease of the liver and plasma and GOT in CCl4-treated rats after 12, 18, and 24 h, and the control rat
12 h 18 h 24 h Control
Caspase-3-like protease (pmol/mg protein/min)
Liver 20.31 þ 1.91* 20.75 þ 4.34* 24.18 þ 4.49** 13.46 þ 1.50
Plasma 1.09 þ 0.79 1.01 þ 0.32 3.92 þ 2.86** 0.03 þ 0.03
Plasma GOT (Karmen unit)
1656 þ 1175* 2441 þ 1362** 8250 þ 1453** 89.5 þ 9.7
A mixture of CCl4 and mineral oil (1:1, 4 ml/kg) was orally administered to rats. After 12, 18, and 24 h, activities of caspase-3-like
protease in the liver and plasma and plasma GOT were determined as described in the text. Control rats received mineral oil and the
enzyme activity was determined after 24 h. Values are mean þ S.D. for 4^6 rats, and asterisks indicate signi¢cant di¡erence from the
corresponding control group (ANOVA Bonferroni/Dunn procedure, *P6 0.05 and **P6 0.01).
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tically to 40% of the control group after 18 h (Table
2). After 24 h, vitamin C in the liver still decreased to
32% of the control group (Table 2). Although vita-
min C is not a vitamin for Wistar rats, excessive liver
damage and oxidative stress caused by CCl4 may
deplete vitamin C. Recently, we reported that the
concentration of vitamin C was decreased in the tis-
sues of Wistar rats that were made diabetic [7] with
streptozotocin and were administered thioacetamide
[8]. These results suggest that the tissue concentration
of vitamin C is a good indicator of oxidative stress
even in Wistar rats.
The plasma concentration of vitamin C tended to
increase 12 h after CCl4 administration, although
there was no signi¢cant di¡erence observed. This ten-
dency may be explained on the grounds that vitamin
C is released just as GOT from the liver whose con-
tent of vitamin C is higher than that of plasma by
two orders of magnitude in the control rat (Table 2).
Similar results were obtained in the case of thio-
acetamide intoxication [8].
The level of hydrophobic vitamin E was not af-
fected either in plasma or in the liver 12, 18, and
24 h after CCl4 administration at this dose (Table
2). Since liver vitamin C is predominantly decreased
by CCl4, these results suggest that extensive lipid
phase peroxidation to consume vitamin E did not
take place by CCl4 but that the oxidative stress in
the aqueous phase to deplete vitamin C took place
exclusively. This result seems to contradict the widely
held view that CCl4 generates trichloromethyl radical
with the reaction with cytochrome P450, a redox
active hemoprotein [1,2] and causes extensive lipid
peroxidation. ESR spectrum [27,28] and in vitro
chemical reactions [29,30] clearly show the radical
generation from CCl4 and cytochrome P450. Even
the activation of CCl4 to dichlorocarbene by cyto-
chrome P450 was reported [31]. However, we re-
ported [18] that speci¢cally determined lipid hydro-
peroxides were not increased in either the whole liver
or the microsomal fraction but were increased
slightly in mitochondria. Therefore, it is suggested
that CCl4 does not cause extensive lipid peroxidation
in microsomes but induces the damage of mitochon-
dria which also contain hemoproteins and generate
radicals by the reaction with CCl4 [32], resulting in
the inactivation of cytochrome oxidase [18].
It is worthwhile to note that the inhibition of cy-
tochrome oxidase precedes the decomposition of
heme a, a prosthetic group of cytochrome oxidase
[18]. This observation suggests that radicals gener-
ated by the hemoprotein and CCl4 initially attack
the protein part of the enzyme [18]. We have dem-
onstrated that apolipoprotein B is much more reac-
tive to radicals than other proteins such as albumin
and transferrin and is easily decomposed in plasma
[33^35]. The high reactivity of apolipoprotein B is
explained on the ground that apolipoprotein B forms
LDL particle with lipids that are highly reactive to
radical species [35]. Cytochrome oxidase is a mem-
brane protein and it also has neighboring lipids such
as apolipoprotein B. The decomposition of cyto-
chrome P450 protein, also a membrane-bound pro-
tein in CCl4-treated rat liver was reported [29]. The
high reactivity of proteins to radical reaction may
explain the reason why vitamin C, a hydrophilic anti-
oxidant, is predominantly consumed in CCl4 intoxi-
cation. It is also possible that trichloromethyl radical
generated from CCl4 and hemoproteins rapidly re-
acts with oxygen to form trichloromethylhydroper-
Table 2
Concentration of vitamin C and vitamin E of the liver and plasma in CCl4-treated rats after 12, 18, and 24 h, and the control group
Vitamin C (nmol/g tissue) Vitamin E (nmol/g tissue)
Plasma Liver Plasma Liver
After 12 h 74.7 þ 18.5 821 þ 485 7.4 þ 2.8 27.6 þ 2.5
After 18 h 55.8 þ 9.4 473 þ 334* 6.6 þ 1.7 29.7 þ 5.7
After 24 h 67.9 þ 5.0 376 þ 215** 10.0 þ 5.3 24.2 þ 2.8
Control 57.0 þ 35.8 1188 þ 276 10.8 þ 3.1 24.5 þ 4.9
A mixture of CCl4 and mineral oil (1:1, 4 ml/kg) was orally administered to rats. After 12, 18, and 24 h, concentrations of vitamin C
and vitamin E in the plasma and liver were determined as described in the text. After 24 h of the administration of mineral oil, deter-
minations were made for control rats. Values are mean þ S.D. of 4^6 rats, and asterisks indicate signi¢cant di¡erence from the control
group (ANOVA Bonferroni/Dunn procedure, *P6 0.05 and **P6 0.01).
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oxy radical, which is much more hydrophilic than
trichloromethyl radical. This idea may also explain
why hydrophilic antioxidant is consumed predomi-
nantly.
3.3. Oxidative stress, apoptosis, and necrosis
Twelve hours after the administration of CCl4, the
activation of caspase-3 took place but the decrease of
vitamin C in the liver was not signi¢cant. The in-
volvement of reactive oxygen species in apoptosis
has been suggested. Recently we reported [36] that
hydroxyl radicals were involved in the apoptosis of
HL-60 cells caused by anticancer drugs based on
systematic evaluation of di¡erent kinds of antioxi-
dants. We reported further [36] that the radicals dur-
ing the apoptotic process did not markedly decrease
the cellular concentration of vitamin E. Therefore,
the decrease of vitamin C in the liver 18 and 24 h
after CCl4 administration may be induced by ne-
crosis judging from the increase of GOT at 12 h.
This is in sharp contrast to the case of thioacetamide
(500 mg/kg body weight), which typically increased
lipid hydroperoxides and decreased both vitamins C
and E in the liver. Previously [8] we did not clarify
whether necrosis was caused by radical reaction or
radical reaction is a result of necrosis. The present
study demonstrates that necrosis does not always in-
volve extensive lipid peroxidation. Therefore, it is
suggested that radical reaction is a cause of necrosis
caused by thioacetamide.
Along with radical reactions, increase of calcium
content of the liver [37,38] and liver mitochondria
[39] by CCl4 was reported. Since it is well docu-
mented that cellular calcium concentration transi-
ently augments in cell death [40], it is probable that
damage of the respiratory chain in mitochondria [3]
and the resulting disorder of calcium metabolism
[38,39,41] by CCl4 are the main cause of apoptosis
and necrosis of the liver cell.
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